Health care costs and resource utilization, including patient burden, associated with novel-agent-based treatment versus other therapies for multiple myeloma: findings using real-world claims data
General Info
Time period covered
January, 2005 - December, 2010
Data type
Scientific literature
Keywords
Citation
Journal
Oncologist
Pages
37-45
Publication year
2013
Suggested citation
Teitelbaum A, Ba-Mancini A, Huang H, Henk HJ. Health care costs and resource utilization, including patient burden, associated with novel-agent-based treatment versus other therapies for multiple myeloma: findings using real-world claims data. Oncologist. 2013; 18(1): 37-45.